Tag: Dexcom
Dexcom partners with, invests in, Ōura
November 21, 2024HME News Staff
SAN DIEGO & SAN FRANCISCO – Dexcom’s glucose data with be integrated with the Oura Ring’s vital sign, sleep, stress, heart health and activity data to provide users of both products with a more complete picture of overall health, the companies say. Dexcom is also making a $75 million strategic investment in Ōura’s Series D funding, putting the company’s valuation at more than $5 billion. “Dexcom offers the most accurate glucose biosensing systems on the market...
Tandem, Dexcom integration approved in Canada
August 1, 2024HME News Staff
MARKHAM, Ontario – Tandem Diabetes Care and Dexcom have announced the updated t:slim X2 insulin pump software is compatible with both Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems and is authorized for sale by Health Canada. This integration allows users of the t:slim X2 insulin pump with Control-IQ technology, to have even more choice in how they manage their diabetes. "This integration marks the first time an AID system in Canada is compatible with both Dexcom G7...
Tandem integrates with Dexcom
May 29, 2024HME News Staff
SAN DIEGO – The Tandem Mobi insulin pump with Control-IQ technology is now fully compatible with both the Dexcom G7 and Dexcom G6 continuous glucose monitoring systems (CGMs). Tandem Mobi, an automated delivery system (AID), launched in the United States earlier this year. “Choice is a hallmark of our offerings, and we’ve proven this commitment with the expansion of our insulin pump portfolio and extended CGM compatibilities,” said John Sheridan, president and CEO of Tandem...
In brief: Dexcom study, test strip fraud, InfuSystem stock buy-back
May 24, 2024HME News Staff
LONDON – Nearly half of patients with Type 2 diabetes were unaware of the disease’s effects, according to a new study from Dexcom.
The “Dexcom State of Type 2 Report,” released in conjunction with the launch of the Dexcom ONE+ continuous glucose monitor, also found:
63% of people with diabetes are encountering difficulties in managing their disease, including challenges related to improving their diet or their mental health; and
42% of...
Dexcom releases study, launches new CGM
May 22, 2024HME News Staff
LONDON – Nearly half of patients with Type 2 diabetes were unaware of the disease’s effects, according to a new study from Dexcom.
The “Dexcom State of Type 2 Report,” released in conjunction with the launch of the Dexcom ONE+ continuous glucose monitor, also found:
63% of people with diabetes are encountering difficulties in managing their disease, including challenges related to improving their diet or their mental health; and
42% of...
MD Revolution, Dexcom integrate
April 10, 2024HME News Staff
SAN DIEGO – MD Revolution’s remote care management platform will be integrated with Dexcom’s continuous glucose monitoring systems as part of a new partnership. As a result, a patient’s glucose monitoring data can be made available to clinicians through MD Revolution’s platform, empowering clinicians to make informed decisions and provide better support for patients. "This integration further strengthens our scalable care management platform and ecosystem of integrated...
Dexcom to introduce OTC glucose sensor
March 6, 2024HME News Staff
SAN DIEGO – Dexcom has received clearance from the U.S. Food and Drug Administration for its Stelo by Dexcom, a continuous glucose monitor that will be available for people with Type 2 diabetes without a prescription. “Dexcom continues to lead innovation in the CGM market, with a long list of first-in-market advances,” said Jake Leach, executive vice president and COO. “Dexcom was the first to connect CGM to multiple insulin delivery devices, the first to connect CGM to a...
In brief: Senators’ demands, F&P’s new execs, Belluscura’s green light
December 21, 2023HME News Staff
WASHINGTON – A group of senators has asked CMS to collect and publish more Medicare Advantage data to help lawmakers and regulators better understand the impact of these plans.
AAHomecare provided the following analysis of the group's new letter to CMS Administrator Chiquita Brooks-Lasure:
The senators cite “concerning trends” in Medicare Advantage and point to a 2019 HHS OIG study that “found that among requests MA plans denied, 13% of prior...
Dexcom’s G7 now connects with Tandem’s t:slim X2
December 21, 2023HME News Staff
SAN DIEGO – Dexcom’s G7 continuous glucose monitoring (CGM) system can now connect with Tandem Diabetes Care's t:slim X2 insulin pump. Dexcom in December 2022 received clearance from the U.S. Food and Drug Administration for the device, which can be used for people with all types of diabetes ages two years and older. The G7 features a simplified, redesigned app experience; 30-minute sensor warm up; 12-hour grace period to replace finished sensors; and enhanced alerts. Dexcom G7 sensors...
In brief: Journey Health buy, Philips complaint count, AI-based HST
February 17, 2023HME News Staff
RICHMOND, Va., and SAN DIEGO – Journey Health & Lifestyle Brands has acquired LifeWalker Mobility Products, the manufacturer and distributor of the UPWalker family of products.
The acquisition, as well as additional growth capital for the combined companies, was funded by Peloton Equity and other existing investors in Journey Health, including Escalate Capital.
“We are excited to bring LifeWalker's revolutionary UPWalker products into the Journey family,”...